237 related articles for article (PubMed ID: 11313287)
1. Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma.
Drayson M; Tang LX; Drew R; Mead GP; Carr-Smith H; Bradwell AR
Blood; 2001 May; 97(9):2900-2. PubMed ID: 11313287
[TBL] [Abstract][Full Text] [Related]
2. [Progress in the management of multiple myeloma introduced by serum free light chain measurement].
Fuchida S; Shimazaki C
Nihon Rinsho; 2011 Dec; 69(12):2267-73. PubMed ID: 22242331
[TBL] [Abstract][Full Text] [Related]
3. Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine.
Bradwell AR; Carr-Smith HD; Mead GP; Tang LX; Showell PJ; Drayson MT; Drew R
Clin Chem; 2001 Apr; 47(4):673-80. PubMed ID: 11274017
[TBL] [Abstract][Full Text] [Related]
4. Detection of kappa and lambda light chain monoclonal proteins in human serum: automated immunoassay versus immunofixation electrophoresis.
Jaskowski TD; Litwin CM; Hill HR
Clin Vaccine Immunol; 2006 Feb; 13(2):277-80. PubMed ID: 16467338
[TBL] [Abstract][Full Text] [Related]
5. Analytical performance and diagnostic potential of immunoassays determining intact immunoglobulin kappa/lambda ratios in monoclonal gammopathies.
Eckold J; Poenisch W; Drogies T; Kratzsch J; Teupser D; Thiery J; Bruegel M
Clin Lab; 2014; 60(9):1491-500. PubMed ID: 25291945
[TBL] [Abstract][Full Text] [Related]
6. Biclonal plasma cell myeloma with the simultaneous appearance of both secretory lambda and nonsecretory kappa monoclonal light chains.
Gu HJ; Cho SY; Lee J; Sung JY; Park TS
Clin Chem Lab Med; 2017 Jan; 55(1):e21-e24. PubMed ID: 27442368
[No Abstract] [Full Text] [Related]
7. Interpretation Difficulties of Serum Immunofixation Test in Immunoglobulin D Multiple Myeloma with Hidden Lambda Light Chains.
Biaz A; Uwingabiye J; Rachid A; Dami A; Bouhsain S; Ouzzif Z; Idrissi SEM
Clin Lab; 2018 Jun; 64(6):1065-1069. PubMed ID: 29945318
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of the new Hevylite™ IgA assay for the diagnosis and follow-up of monoclonal gammopathies].
Lakomy D; Lemaire-Ewing S; Denimal D; Bastie JN; Lafon I; Caillot D
Ann Biol Clin (Paris); 2013; 71(2):157-63. PubMed ID: 23587579
[TBL] [Abstract][Full Text] [Related]
9. Polyclonal free light chain of Ig may interfere with interpretation of monoclonal free light chain κ/λ ratio.
Levinson SS
Ann Clin Lab Sci; 2010; 40(4):348-53. PubMed ID: 20947809
[TBL] [Abstract][Full Text] [Related]
10. Assessment of monoclonal gammopathies by nephelometric measurement of individual immunoglobulin kappa/lambda ratios.
Bradwell AR; Harding SJ; Fourrier NJ; Wallis GL; Drayson MT; Carr-Smith HD; Mead GP
Clin Chem; 2009 Sep; 55(9):1646-55. PubMed ID: 19617289
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of the clinical relevance of serum measurements of free-light chains in patients with multiple myeloma].
Shimizu K; Itoh J; Sugiura I; Tsushita K; Kosugi H; Nagura E
Rinsho Ketsueki; 2006 Apr; 47(4):303-9. PubMed ID: 16715965
[TBL] [Abstract][Full Text] [Related]
12. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.
Katzmann JA; Clark RJ; Abraham RS; Bryant S; Lymp JF; Bradwell AR; Kyle RA
Clin Chem; 2002 Sep; 48(9):1437-44. PubMed ID: 12194920
[TBL] [Abstract][Full Text] [Related]
13. Comparison of free κ and λ light chain immunoassays and total (bound and free) κ and λ light chain immunoassays.
Delgado F; Kuus K
Rev Invest Clin; 2014; 66(5):473-4. PubMed ID: 25695391
[No Abstract] [Full Text] [Related]
14. Measurement of free kappa and lambda chains in serum and the significance of their ratio in patients with multiple myeloma.
Nelson M; Brown RD; Gibson J; Joshua DE
Br J Haematol; 1992 Jun; 81(2):223-30. PubMed ID: 1643019
[TBL] [Abstract][Full Text] [Related]
15. Correlation of serum immunoglobulin free light chain quantification with urinary Bence Jones protein in light chain myeloma.
Abraham RS; Clark RJ; Bryant SC; Lymp JF; Larson T; Kyle RA; Katzmann JA
Clin Chem; 2002; 48(4):655-7. PubMed ID: 11901068
[No Abstract] [Full Text] [Related]
16. [Measurement of serum free light chains and its clinical significance in 20 newly diagnosed patients of multiple myeloma].
Mao XB; Chen XQ; Zhai YP; Liang R; Gao GX; Ma GG; Yu YP; Li F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):829-32. PubMed ID: 18718070
[TBL] [Abstract][Full Text] [Related]
17. IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myeloma.
Boyle EM; Fouquet G; Guidez S; Bonnet S; Demarquette H; Dulery R; Herbaux C; Noel MP; Manier S; Schraen S; Onraed B; Faucompré JL; Hennache B; Petillon MO; Mathiot C; Avet-Loiseau H; Facon T; Harding SJ; Moreau P; Leleu X
Cancer; 2014 Dec; 120(24):3952-7. PubMed ID: 25116271
[TBL] [Abstract][Full Text] [Related]
18. Sharply increased serum free light-chain concentrations after treatment for multiple myeloma.
Murata K; Clark RJ; Lockington KS; Tostrud LJ; Greipp PR; Katzmann JA
Clin Chem; 2010 Jan; 56(1):16-8. PubMed ID: 20040623
[No Abstract] [Full Text] [Related]
19. Practical considerations for the measurement of free light chains in serum.
Tate JR; Gill D; Cobcroft R; Hickman PE
Clin Chem; 2003 Aug; 49(8):1252-7. PubMed ID: 12881439
[TBL] [Abstract][Full Text] [Related]
20. Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma.
Dejoie T; Attal M; Moreau P; Harousseau JL; Avet-Loiseau H
Haematologica; 2016 Mar; 101(3):356-62. PubMed ID: 26635032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
